Skip to content

Clinical trials

Phase 3 Leiomyoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyoma Phase: Phase 3 Country / region: United States Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20062
20083
20092
20121
20142
20151
20162
20177
20183
20191
20201
20212
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Terminated9
Withdrawn2
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Repros Therapeutics Inc.6
AbbVie4
Myovant Sciences GmbH4
Bayer3
Allergan2
InSightec2
ObsEva SA2
Sumitomo Pharma Switzerland GmbH2
Eastern Virginia Medical School1
University of California, Irvine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyoma31
Menorrhagia12
Myofibroma5
Endometriosis2
Uterine Hemorrhage2
Anemia1
Metrorrhagia1
Neoplasms1
Ovarian Neoplasms1
Uterine Neoplasms1

Trials

Showing 1 to 25 of 31. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.